Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Executive Summary
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
You may also be interested in...
Recordati Posts 2021 Sales Rise As Market Recovers
Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.
Ireland Reviewing Codeine's OTC Status
Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.
OTC Marketing Awards 2022: What The Judges Said About The Leading Entries
The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?